Table 1.
Antimicrobial susceptibility rate (%) of CPE isolates (n = 152) from 2016 to 2021, Havana, Cuba.
| Antimicrobials 1 | Susceptibility 2 | Bacterial Species | ||||||
|---|---|---|---|---|---|---|---|---|
| K. peumoniae | Enterobacter cloacae complex | E. coli | K. aerogenes | S. marcescens | Others 3 | Total | ||
| (n = 106) | (n = 20) | (n = 9) | (n = 6) | (n = 6) | (n = 5) | (n = 152) | ||
| SAM | R | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| TZP | R | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| MEM | I | 2% | 0% | 0% | 17% | 0% | 20% | 3% |
| R | 98% | 100% | 100% | 83% | 100% | 80% | 97% | |
| IPM | I | 4% | 5% | 0% | 17% | 0% | 20% | 5% |
| R | 96% | 95% | 100% | 83% | 100% | 80% | 95% | |
| ATM | S | 1% | 10% | 11% | 17% | 0% | 20% | 4% |
| I | 0% | 0% | 11% | 0% | 0% | 0% | 1% | |
| R | 99% | 90% | 78% | 83% | 100% | 80% | 95% | |
| CIP | S | 8% | 10% | 33% | 0% | 17% | 0% | 10% |
| I | 1% | 0% | 0% | 0% | 0% | 0% | 1% | |
| R | 91% | 90% | 67% | 100% | 83% | 100% | 89% | |
| GEN | S | 5% | 5% | 11% | 0% | 0% | 0% | 5% |
| I | 2% | 0% | 0% | 0% | 0% | 0% | 1% | |
| R | 93% | 95% | 89% | 100% | 100% | 100% | 94% | |
| AMK | S | 8% | 10% | 22% | 0% | 0% | 0% | 8% |
| I | 2% | 0% | 11% | 0% | 0% | 0% | 2% | |
| R | 90% | 90% | 67% | 100% | 100% | 100% | 90% | |
| SXT | S | 3% | 0% | 22% | 0% | 17% | 0% | 4% |
| I | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| R | 97% | 100% | 78% | 100% | 83% | 100% | 96% | |
| FOS | S | 22% | 20% | 78% | 0% | 17% | 20% | 24% |
| I | 4% | 5% | 0% | 0% | 33% | 0% | 5% | |
| R | 74% | 75% | 22% | 100% | 50% | 80% | 71% | |
| CST 4 | S | 75% | 75% | 100% | 67% | - | 100% | 73% |
| I | 0% | 0% | 0% | 0% | - | 0% | 0% | |
| R | 25% | 25% | 0% | 33% | - | 0% | 27% | |
| TGC | S | 58% | 75% | 67% | 83% | 66% | 80% | 63% |
| I | 27% | 10% | 22% | 17% | 17% | 0% | 23% | |
| R | 15% | 15% | 11% | 0% | 17% | 20% | 14% | |
1 Abbreviation: SAM, ampicillin-sulbactam (SAM); TZP, piperacillin-tazobactam; MEM, meropenem; IPM, imipenem; ATM, aztreonam; CIP, ciprofloxacin; GEN, gentamicin; AMK, amikacin; SXT, trimethoprim-sulfamethoxazole; FOS, fosfomycin; CST, colistin; TGC, tigecycline. 2 S, susceptible; I, intermediate; R, resistant. 3 others: C. koseri, C. freundii, K. oxytoca, M. morganii. 4 Susceptibility rate is not shown for S. marcaescens and M. morganii, because these species are intrinsically resistant to CST.